LND topic: pfizer-novartis page 1

pfizer novartis

The Changing Landscape of Drug Discovery: A Look into the Future

December 19, 2025

In 2006, a young journalist visited Pfizer to discuss the company's research and development (R&D) plans. This was a time when the pharmaceutical industry was facing a significant drop in productivity. During the 1990s, the Food and Drug Administration (FDA) approved 311 new medicines. However, in t

health

Vaccines: Guardians of Global Health

November 27, 2025

Vaccines are a big deal in keeping people healthy. They work by teaching the body's defense system to fight off germs. This has helped wipe out diseases like smallpox and made others, like polio, rare. Vaccines also protect whole communities by stopping diseases from spreading. This is called herd i

finance

Pfizer's Path to Growth: Is It Time to Buy?

November 25, 2025

Pfizer has been making waves in the pharmaceutical world. It recently outmaneuvered Novo Nordisk to secure a deal for Metsera. This win has given Pfizer's stock a boost. But the company's success isn't just about one deal. Pfizer's third-quarter earnings were impressive. They beat Wall Street's exp

health

A Big Deal: Texas Takes on Pfizer Over ADHD Meds

November 25, 2025

Texas just made a big move against Pfizer. They settled a lawsuit for $41. 5 million. This was about a medicine called Quillivant XR. It's used to treat ADHD in kids. The issue? Tests showed the drug didn't work as it should. It didn't dissolve in the body. But the company kept saying it was fine.

finance

Pfizer's Move: Should You Reconsider BNTX Stock?

November 25, 2025

Pfizer's decision to offload its remaining shares in BioNTech (BNTX) has raised eyebrows. This move hints at a lack of faith in BioNTech's COVID-19 vaccine and its stock potential. BioNTech, once a profit powerhouse, is now facing significant losses. Its shares, though not cheap, reflect a company s

business

Big Pharma Hits a Trillion-Dollar Jackpot

November 25, 2025

Eli Lilly, a big name in the drug world, just hit a huge milestone. It became the first healthcare company to reach a market value of $1 trillion. That's a lot of money! The company's stock hit this mark briefly during trading but then settled a bit lower, with each share going for around $1, 048.

health

Vaccine Science Under the Microscope

November 20, 2025

In a surprising turn of events, a legal deposition revealed some unsettling facts about vaccine science. Dr. Stanley Plotkin, a well-known figure in the field, admitted to some questionable practices during a custody battle case. The case was about whether a child should be vaccinated or not. Plotk

health

Novartis Expands Cancer Drug Production in the US

November 12, 2025

Novartis, a Swiss pharmaceutical giant, has just opened a new manufacturing plant in Carlsbad, California. This facility is part of a bigger plan to invest $23 billion in the United States over the next five years. The focus of this new plant is on making cancer drugs, specifically for a treatment c

health

Boosting Immunity: COVID Vaccines and Cancer Survival

November 11, 2025

A recent study has uncovered a surprising link between mRNA COVID-19 vaccines and improved survival rates in cancer patients. This isn’t about curing cancer, but it does suggest that these vaccines might give the immune system a helpful nudge. Researchers found that patients with advanced melanoma

business

Kimberly-Clark's Risky Bet on Tylenol Amid Political Heat

November 4, 2025

Kimberly-Clark, a big name in consumer goods, just made a bold move. They bought Kenvue, the company behind Tylenol. But this deal didn't go over well with Wall Street. Their stock took a huge hit, the worst since the big crash in 1987. Shares dropped by 15%, which is a lot. Why did they do it? The